GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » YoY EPS Growth

VRBCF (Virbac) YoY EPS Growth : 26.90% (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Virbac YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Virbac's YoY EPS Growth for the quarter that ended in Jun. 2024 was 26.90%.

Virbac's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was $12.15.


Virbac YoY EPS Growth Historical Data

The historical data trend for Virbac's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac YoY EPS Growth Chart

Virbac Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 149.69 188.86 -22.91 1.03 2.66

Virbac Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.53 1.20 -1.24 8.69 26.90

Virbac YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Virbac's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(15.682-15.275)/ | 15.275 |
=2.66 %

Virbac's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EPS Growth (Q: Jun. 2024 )
=(Earnings per Share (Diluted) (Q: Jun. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(12.153-9.577)/ | 9.577 |
=26.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Virbac YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Virbac's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.

Virbac Headlines

From GuruFocus

Full Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2018 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Virbac SA SFAF Meeting Transcript

By GuruFocus Research 03-08-2024

Full Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024